[HTML][HTML] Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling …

M Taniuchi, M Famulare, K Zaman… - The Lancet Infectious …, 2017 - thelancet.com
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.

M Taniuchi, M Famulare, K Zaman, MJ Uddin… - 2017 - cabidigitallibrary.org
Background: Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

[HTML][HTML] Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling …

M Taniuchi, M Famulare, K Zaman, MJ Uddin… - The Lancet Infectious …, 2017 - Elsevier
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study

M Taniuchi, M Famulare, K Zaman, MJ Uddin… - 2017 - pubmed.ncbi.nlm.nih.gov
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

[HTML][HTML] Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling …

M Taniuchi, M Famulare, K Zaman… - The Lancet. Infectious …, 2017 - ncbi.nlm.nih.gov
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.

M Taniuchi, M Famulare, K Zaman… - The Lancet. Infectious …, 2017 - europepmc.org
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

[PDF][PDF] Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling …

M Taniuchi, M Famulare, K Zaman, MJ Uddin… - Lancet Infect …, 2017 - academia.edu
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.

M Taniuchi, M Famulare, K Zaman… - The Lancet. Infectious …, 2017 - europepmc.org
Background Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by
bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine …